跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 287 条关于
“Rubix LS”
全部
287
临床试验
116
药物
75
机构
4
资讯
92
去年
TheraSyn Bio and Rubix LS Launch Joint Venture to Develop Novel Topical Breast Cancer Therapy
去年
Kiffik Biomedical and Rubix LS Join Forces to Develop Novel Non-Invasive Colorectal Cancer Test
2年前
Durvalumab Improves Survival in Limited-Stage Small Cell Lung Cancer Subgroups
2个月前
RIO Trial: Long-Acting bNAbs 3BNC117-LS and 10-1074-LS Delay HIV Rebound and Accelerate Reservoir Decay After Treatment Interruption
去年
Durvalumab Shifts Decades Long SOC as First FDA-Approved Immunotherapy Regimen in LS-SCLC
去年
NRG Oncology/Alliance LU005 Trial: Atezolizumab Fails to Improve Survival in Limited-Stage SCLC
去年
KIFFIK Biomedical Strengthens Leadership with Strategic Appointments to Advance Interstitial Fluid Diagnostics
2年前
FDA Grants Priority Review and Breakthrough Therapy Designation to Imfinzi for Limited-Stage Small Cell Lung Cancer
2年前
TransCon CNP Demonstrates Superior Growth in Achondroplasia Trial
去年
Thiogenesis Announces Clinical Trial Updates for MELAS and Leigh Syndrome
第 1 页,共 10 页
上一页
下一页